![Steven Burke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Burke
Directeur Technique/Scientifique/R&D chez
AKEBIA THERAPEUTICS, INC.
Fortune : 502 783 $ au 31/08/2026
Profil
Steven K.
Burke is currently Director at LeukoSight, Inc. and AbFero Pharmaceuticals, Inc. Since 2019, Dr. Burke has been Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. Formerly, Dr. Burke was Medical Director & VP-Clinical Research at GelTex Pharmaceuticals, Inc. from 1994 to 2001, Associate Director-Clinical Research at Glaxo, Inc., Senior VP-Medical and Regulatory Affairs at Genzyme Corp.
in 2011, Chief Medical Officer & Senior Vice President at Proteon Therapeutics, Inc. from 2006 to 2019, and Chief Medical Officer at Protara Therapeutics, Inc. Education includes a doctorate from Weill Cornell Medical College and undergraduate studies at Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 547 098 ( 0,2 % ) | 502 783 $ | 31/08/2026 |
Postes actifs de Steven Burke
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2019 |
LeukoSight, Inc.
 LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Directeur/Membre du Conseil | - |
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Directeur/Membre du Conseil | - |
Anciens postes connus de Steven Burke
| Sociétés | Poste | Fin |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2019 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/01/2001 |
| PROTARA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Directeur Technique/Scientifique/R&D | - |
Formation de Steven Burke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
